Autologous hematopoietic stem cell transplantation reverses skin fibrosis but does not change skin vessel density in patients with systemic sclerosis

Pathologie Biologie

Volumn 63, Issue 4-5, 2015, Pages 164-168

  Daikeler, T ^a   Kump, E ^a   Stern, M ^a   Hugle T ^a   Hij, A ^b   Haeuserman, P ^a   Farge, D ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Autologous; Fibrosis; HSCT; Skin; Systemic sclerosis; Vessels

Indexed keywords

CD31 ANTIGEN; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CUTANEOUS PARAMETERS; DERMIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOLOGICAL SKIN FIBROSIS SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; MALE; MODIFIED RODNAN SKIN SCORE; PUNCH BIOPSY; SKIN BIOPSY; SKIN DISEASE ASSESSMENT; SKIN FIBROSIS; SKIN VESSEL DENSITY; SYSTEMIC SCLEROSIS; AUTOTRANSPLANTATION; BIOPSY; CAPILLARY; CHEMISTRY; FIBROSIS; MIDDLE AGED; PATHOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN; VASCULAR ENDOTHELIUM; VASCULARIZATION; YOUNG ADULT;

ADULT; BIOMARKERS; BIOPSY; CAPILLARIES; DERMIS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 84941811724     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2015.07.006     Document Type: Article

References (15)

1. Furst D.E., Clements P.J. Hypothesis for the pathogenesis of systemic sclerosis. J Rheumatol Suppl 1997, 48:53-57.
2. Kahaleh M.B. Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 2004, 22:S19-S23.
3. Fransen J., Popa-Diaconu D., Hesselstrand R., Carreira P., Valentini G., Beretta L., et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis 2011, 10.1136/ard.2010.144360.
4. Van Laar J.M., Farge D., Sont J.K., Naraghi K., Marjanovic Z., Larghero J., et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA J Am Med Assoc 2014, 311:2490-2498.
5. Nash R.A., McSweeney P.A., Crofford L.J., Abidi M., Chen C.-S., Godwin J.D., et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 2007, 110:1388-1396.
6. Verrecchia F., Laboureau J., Verola O., Roos N., Porcher R., Bruneval P., et al. Skin involvement in scleroderma-where histological and clinical scores meet. Rheumatol Oxf Engl 2007, 46:833-841.
7. Sulli A., Pizzorni C., Smith V., Zampogna G., Ravera F., Cutolo M. Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum 2012, 64:821-825.
8. Aschwanden M., Daikeler T., Jaeger K.A., Thalhammer C., Gratwohl A., Matucci-Cerinic M., et al. Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease. Ann Rheum Dis 2008, 67:1057-1059.
9. Fleming J.N., Nash R.A., McLeod D.O., Fiorentino D.F., Shulman H.M., Connolly M.K., et al. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?. PloS One 2008, 3:e1452.
10. Clements P., Lachenbruch P., Siebold J., White B., Weiner S., Martin R., et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995, 22:1281-1285.
11. Haeusermann P., Kump E., Rovó A., Tichelli A., Itin P., Gratwohl A., et al. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation. Dermatol Basel Switz 2009, 219:32-41.
12. Smith B.D., Moliterno A.R. Biology and management of idiopathic myelofibrosis. Curr Opin Oncol 2001, 13:91-94.
13. O'Reilly S., Hügle T., van Laar J.M. T cells in systemic sclerosis: a reappraisal. Rheumatol Oxf Engl 2012, 51:1540-1549.
14. Baraut J., Michel L., Verrecchia F., Farge D. Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 2010, 10:65-73.
15. Miniati I., Guiducci S., Conforti M.L., Rogai V., Fiori G., Cinelli M., et al. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann Rheum Dis 2009, 68:94-98.